A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers-Reference-Cited by-同舟云学术

A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers

Published:2021-07-22 Issue:10 Volume:125 Page:1333-1340
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Zhang Bingnan,Ramkumar Kavya,Cardnell Robert John,Gay Carl Michael,Stewart C. Allison,Wang Wei-Lien,Fujimoto Junya,Wistuba Ignacio I.,Byers Lauren Averett^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-021-01476-w.pdf

Reference79 articles.

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

2. Lee JM, Ledermann JA, Kohn EC. PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies. Ann Oncol. 2014;25:32–40.

3. Schwarz DA, Katayama CD, Hedrick SM. Schlafen, a new family of growth regulatory genes that affect thymocyte development. Immunity. 1998;9:657–68.

4. Ferguson DA, Chiang JT, Richardson JA, Graff J. eXPRESSION: an in silico tool to predict patterns of gene expression. Gene Expr Patterns. 2005;5:619–28.

5. Neumann B, Zhao L, Murphy K, Gonda TJ. Subcellular localization of the Schlafen protein family. Biochem Biophys Res Commun. 2008;370:62–66.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of SLFN11 in DNA replication stress response and its implications for the Fanconi anemia pathway;DNA Repair;2024-09

2. Targeting DNA Damage Response Deficiency in Thoracic Cancers;Drugs;2024-07-13

3. Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks;Oncogene;2024-07-03

4. Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients;Molecular Oncology;2024-07-02

5. CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer;Nature Reviews Urology;2024-07-01